Radiological isotopes - tauvid, amyvid, cerianna

Ended Purchase Order Awarded Last action

Contract number
HT940623P0207
Awardee
Awarding agency
Obligated
$137,294

Award facts

Opportunity
  • HT940623R0023 Solicitation number
Contract value 100% obligated
$137,293.52 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Knoxville, TN 37932, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00010 $30,055
Supplemental Agreement for work within scope P00009 $0
Exercise an Option P00008 $0
Supplemental Agreement for work within scope P00007 -$65,073
Other Administrative Action P00006 · Radiological isotopes $0
Supplemental Agreement for work within scope P00005 · Cerianna $1,821
Funding Only Action P00004 · Radiological isotopes $85,245
Exercise an Option P00003 · Drop shipments of radiological pharmaceuticals such as tauvid, amyvid, and cerianna $0
Funding Only Action P00002 $85,245
Supplemental Agreement for work within scope P00001 · Radiological pharmaceuticals (radiological isotopes) $0
Original award $0
Show all 11

About this award

Petnet Solutions, Inc., a Knoxville, Tennessee-based manufacturer of radiopharmaceutical products owned by Siemens Aktiengesellschaft, was awarded a firm fixed-price purchase order by the Defense Health Agency on October 1, 2023, with a ceiling value of $137,293.52 and an ultimate completion date of September 30, 2026. The contract covers the supply of radiological isotopes including Tauvid (flortaucipir F-18), Amyvid (florbetapir F-18), and Cerianna, which are specialized diagnostic imaging agents used in positron emission tomography and computed tomography scans. These radiopharmaceuticals are critical tools for detecting and monitoring conditions such as cancer, neurological disorders, and cardiac diseases across military treatment facilities. The award was made without a set-aside designation, reflecting Petnet Solutions' competitive capabilities in this specialized market.

This purchase order represents a component of Petnet Solutions' extensive federal healthcare supply portfolio, which includes multiple indefinite delivery contracts and blanket purchase agreements with the Department of Veterans Affairs and Defense Health Agency valued at tens of millions of dollars collectively. The company has been a registered federal contractor since April 2001 and supplies radiopharmaceutical products to numerous Veterans Integrated Service Networks, military treatment facilities including Fort Sam Houston and Wright-Patterson Air Force Base, and other federal healthcare providers. The contract supports the Defense Health Agency's mission to provide medical services and support to active-duty military personnel and other military beneficiaries across the federal healthcare system.

Quick answers

Who was awarded contract HT940623P0207?

HT940623P0207 was awarded to Petnet Solutions, Inc. by Defense Health Agency (Department of Defense) on October 1, 2023.

How much is contract HT940623P0207 worth?

The government has obligated $137,294 on HT940623P0207.

Was contract HT940623P0207 competed?

The extent of competition for HT940623P0207 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award